MLYS
Mineralys Therapeutics, Inc.
27.62
1 x 19.75
2 x 34.20
bid
ask
+
0.73
2.73%
10:18 AM
timesize
| Ytd | -23.88% | |
| 1y | 93.17% |
26.79
day range
27.77
12.59
52 week range
47.65
| Open | 27.20 | Prev Close | 26.89 | Low | 26.79 | High | 27.77 | Mkt Cap | 2.44B |
| Vol | 105.51K | Avg Vol | 1.58M | EPS | -1.97 | P/E | N/A | Forward P/E | -12.83 |
| Beta | 0.56 | Short Ratio | 4.41 | Inst. Own | 107.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 27.21 | 200-d Avg | 32.72 | 1yr Est | 49.00 |
| Income Statement | |||
| Operating Expenses | 45.34M | ||
| Research and Development Expense | 24.37M | ||
| Selling, General and Administrative Expense | 20.98M | ||
| Operating Income | -45.34M | ||
| Net Income | -39.34M | ||
| Net Income Common Stock | -39.34M | ||
| Net Income Common Stock (USD) | -39.34M | ||
| Consolidated Income | -39.34M | ||
| Earnings per Basic Share | -0.47 | ||
| Earnings per Basic Share (USD) | -0.47 | ||
| Earnings per Diluted Share | -0.47 | ||
| Earning Before Interest & Taxes (EBIT) | -39.34M | ||
| Earning Before Interest & Taxes (USD) | -39.34M | ||
| Weighted Average Shares | 82.83M | ||
| Weighted Average Shares Diluted | 82.83M | ||
| Balance Sheet | |||
| Cash and Equivalents | 112.78M | ||
| Cash and Equivalents (USD) | 112.78M | ||
| Investments | 533.28M | ||
| Investments Current | 533.28M | ||
| Current Assets | 652.47M | ||
| Property, Plant & Equipment Net | 32.00K | ||
| Total Assets | 652.86M | ||
| Current Liabilities | 14.72M | ||
| Total Liabilities | 14.72M | ||
| Accumulated Retained Earnings (Deficit) | -496.51M | ||
| Shareholders Equity | 638.14M | ||
| Shareholders Equity (USD) | 638.14M | ||
| Assets Non-Current | 392.00K | ||
| Trade and Non-Trade Payables | 1.12M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.00K | ||
| Net Cash Flow from Financing | 24.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -60.14M | ||
| Issuance (Purchase) of Equity Shares | 24.27M | ||
| Net Cash Flow from Investing | -44.94M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -44.94M | ||
| Net Cash Flow from Operations | -39.47M | ||
| Share Based Compensation | 6.55M | ||